bioRxiv ScienceSearch

Biology subjects

Patient, R.

Publications and source records attributed to Patient, R..

2 recordsLinked to original sources

Vegfa expression is activated through positive and negative transcriptional regulatory networks controlled by the ETS factor Etv6 in vivo

VEGFA signaling is crucial for physiological and pathological angiogenesis and hematopoiesis. Although many context-dependent signaling pathways downstream of VEGFA have been uncovered, vegfa transcriptional regulation in vivo remains unclear. Here we show that the ETS transcription factor, Etv6, positively regulates vegfa expression during Xenopus blood stem cell development through multiple transcriptional inputs. In agreement with its established repressive functions, Etv6 directly inhibits the expression of the vegfa repressor, foxo3. Surprisingly, it also directly activates the expression of the vegfa activator, klf4. Finally, it indirectly binds to the vegfa promoter where it co-localizes with Klf4. Klf4 deficiency downregulates vegfa expression and significantly decreases Etv6 binding to the vegfa promoter, indicating that Klf4 recruits Etv6 to the vegfa promoter. Thus, our work uncovers a dual function for Etv6, as both a transcriptional repressor and activator, in controlling a major signaling pathway involved in blood and endothelial development in vivo. Given the established relationships between development and cancer, this elaborate gene regulatory network may inform new strategies for the treatment of VEGFA-dependent tumorigenesis.

developmental biology

CBFβ initiates the hematopoietic stem cell program without obligatory binding to RUNX

Hematopoietic stem cells (HSCs) emerge from hemogenic endothelium (HE) localised in the embryonic dorsal aorta (DA). Here we show that Runx1, a transcription factor essential for HSC emergence, controls HE establishment in the absence of its non-DNA-binding partner, CBF{beta}, and that a CBF{beta}-binding-deficient Runx1 mutant form can activate the HE program in the DA. Nevertheless, CBF{beta} is also essential for HSC emergence by regulating the specification of definitive hemangioblasts (DHs), the precursors of the DA and HE, in the lateral plate mesoderm where it mediates VEGFA induction by BMP signalling. Surprisingly, no Runx gene is expressed in DHs and the pharmacological inhibition of CBF{beta} binding to Runx is not detrimental for DH, confirming that CBF{beta} functions independently of Runx. Thus, we have uncovered, for the first time, that CBF{beta} regulates gene expression without Runx, breaking the dogma in which CBF{beta} s gene regulatory functions are strictly dependent on its binding to Runx.\n\nHIGHLIGHTSO_LIRunx1 and CBF{beta} play independent roles in the establishment of the HSC lineage\nC_LIO_LIRunx1 binding to CBF{beta} is not required for HE establishment\nC_LIO_LICBF{beta} is downstream of BMP and regulates endogenous VEGFA expression in DH\nC_LIO_LIBinding to Runx is not obligatory for CBF{beta} function\nC_LI

developmental biology